Arcadia Investment Management Corp MI lessened its position in shares of Masimo Co. (NASDAQ:MASI – Get Rating) by 61.5% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,932 shares of the medical equipment provider's stock after selling 4,681 shares during the period. Arcadia Investment Management Corp MI's holdings in Masimo were worth $383,000 as of its most recent SEC filing.
A number of other institutional investors have also made changes to their positions in the company. Rhumbline Advisers lifted its holdings in shares of Masimo by 0.7% in the 1st quarter. Rhumbline Advisers now owns 135,981 shares of the medical equipment provider's stock worth $19,791,000 after purchasing an additional 879 shares during the last quarter. Pinebridge Investments L.P. bought a new position in shares of Masimo in the first quarter valued at approximately $445,000. Bank of Nova Scotia raised its holdings in Masimo by 35.4% during the first quarter. Bank of Nova Scotia now owns 1,566 shares of the medical equipment provider's stock worth $228,000 after purchasing an additional 409 shares in the last quarter. Walleye Capital LLC raised its stake in shares of Masimo by 1,656.0% in the 1st quarter. Walleye Capital LLC now owns 18,965 shares of the medical equipment provider's stock worth $2,760,000 after buying an additional 17,885 shares in the last quarter. Finally, Comerica Bank lifted its holdings in Masimo by 3.4% in the 1st quarter. Comerica Bank now owns 23,749 shares of the medical equipment provider's stock valued at $3,235,000 after acquiring an additional 786 shares during the last quarter. 93.31% of the stock is currently owned by institutional investors.
Get
Masimo alerts:
Masimo Trading Down 0.9 %
Masimo stock opened at $141.16 on Friday. Masimo Co. has a one year low of $112.07 and a one year high of $305.21. The company's fifty day moving average price is $149.75 and its two-hundred day moving average price is $141.30. The company has a market capitalization of $7.42 billion, a price-to-earnings ratio of 42.52 and a beta of 0.96. The company has a debt-to-equity ratio of 0.77, a current ratio of 2.10 and a quick ratio of 1.28.
Masimo (NASDAQ:MASI – Get Rating) last posted its quarterly earnings data on Tuesday, August 9th. The medical equipment provider reported $1.35 EPS for the quarter, topping analysts' consensus estimates of $1.19 by $0.16. The business had revenue of $565.30 million for the quarter, compared to analyst estimates of $540.56 million. Masimo had a return on equity of 17.39% and a net
margin of 12.68%. The firm's revenue for the quarter was up 87.9% on a year-over-year basis. During the same period in the previous year, the company posted $0.94 earnings per share. On average, analysts forecast that Masimo Co. will post 4.45 earnings per share for the current fiscal year.
Analyst Upgrades and Downgrades
Several equities research analysts have recently weighed in on MASI shares. Loop Capital initiated coverage on Masimo in a research note on Tuesday, September 13th. They set a "buy" rating and a $206.00 price objective for the company. StockNews.com downgraded Masimo from a "buy" rating to a "hold" rating in a report on Wednesday, August 10th. Piper Sandler upped their price objective on shares of Masimo from $135.00 to $150.00 and gave the company a "neutral" rating in a research note on Friday, September 23rd. Wolfe Research raised shares of Masimo from a "peer perform" rating to an "outperform" rating and set a $165.00 price target on the stock in a research note on Thursday, September 15th. Finally, Needham & Company LLC upped their target price on Masimo from $163.00 to $179.00 and gave the stock a "buy" rating in a research report on Wednesday, August 10th. Three research analysts have rated the stock with a hold rating and five have given a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $194.50.
Masimo Profile
(Get Rating)
Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry.
Further Reading
- Get a free copy of the StockNews.com research report on Masimo (MASI)
- EV Battery Maker Freyr Set For Major Global Expansion
- MarketBeat: Week in Review 9/26 – 9/30
- This Is A Memorable Time To Buy Into Micron Technology
- Declining Profits Challenge the CarMax Value Proposition
- Let Paychex Stock Work Hard For You
Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Co. (NASDAQ:MASI – Get Rating).
Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.
